Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
Muskiet MHA, van Bommel EJM, van Raalte DH The Lancet Diabetes & Endocrinology 2016;4(3):188-9 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00457-X/abstract
Leggi
Breaking news
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study
Weber MA, Mansfield TA, Cain VA, et al. The Lancet Diabetes & Endocrinology 2016;4(3):211-20 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00417-9/abstract
Leggi
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
Dejgaard TF, Frandsen CS, Hansen T, et al. The Lancet Diabetes & Endocrinology 2016;4(3):221-32 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00436-2/abstract
Leggi
Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies
Gijsbers L, Ding EL, Malik VS, et al. Am J Clin Nutr. First pub. online 24 February 2016 http://ajcn.nutrition.org/content/early/2016/02/24/ajcn.115.123216.abstract
Leggi
Use of liraglutide in type 1 diabetes: implications for management
Simmons D The Lancet Diabetes & Endocrinology 2016;4(3):190-1 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00459-3/abstract
Leggi
Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
Lingvay I, Pérez Manghi F, García-Hernández P, et al. JAMA 2016;315(9):898-907 http://jama.jamanetwork.com/article.aspx?articleid=2497908
Leggi
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
Brunström M, Carlberg B BMJ 2016;352:i717 http://www.bmj.com/content/352/bmj.i717
Leggi
Usefulness of highly sensitive troponin as a predictor of short-term outcome in patients with diabetes mellitus and stable coronary artery disease (from the ARTEMIS Study)
Lepojärvi es, Piira O-P, Kiviniemi AM, et al. Am J of Cardiology 2016;117(4):515-21 http://www.ajconline.org/article/S0002-9149(15)02322-X/abstract
Leggi
Systematic review of treatments for diabetic peripheral neuropathy
Çakici N, Fakkel TM, van Neck JW, Verhagen AP, Coert JH Diabetic Medicine. Pub. online 29 January 2016 http://onlinelibrary.wiley.com/doi/10.1111/dme.13083/abstract
Leggi
Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis
Thakkar J, Kurup R, Laba T-L, et al. JAMA Intern Med. Pub. online 1 February 2016 http://archinte.jamanetwork.com/article.aspx?articleid=2484905
Leggi